Skip to main content

Silk, Medical and Serigen

 

In 1600 BC Greek surgeon Galen of Pergamon used silk to suture together gladiators’ severed tendons. This is the first noted use of silk in the medical field. Since then, silk has paved its way into the healthcare industry.






It has garnered special attention which can largely be attributed to its excellent material properties, affordability, and resource ability. Today, it's more than just a suture material.
Silk is a protein polymer that is secreted by a variety of species such as spiders, moths, and butterflies. It has notable properties like low immunogenic response, biodegradability, and biocompatibility. Additionally, studies have proven that silk supports human keratinocytes and fibroblast growth. These factors make it ideal for use in engineering artificial tissue and give it an added advantage over other biomaterials.

In 1992 - technology was discovered - to convert silk fiber into liquid silk. This opened up large possibilities. The liquid silk can then be cast into materials as per requirements.

Serigen is leveraging the material science of natural silk to develop unique tissue regeneration products. 

At Serigen, they convert silk threads (from the cocoons of silkworm Bombyx mori or mulberry silkworm) into a solution. The solution can be structured and shaped in various forms suitable for unique biomedical products.
Their exciting product range consists of - 

  • Seriderm - A single-use disposable dressing. It is non-adherent, and absorbent and ensures regulation of the moisture content at the wound bed.  Complex wounds like diabetic foot ulcers and second-degree burns can heal better with this dressing.
  • Serimat – is a  product helping in soft tissue and blood vessel regeneration. In surgeries for breast cancer with radical soft tissue loss, it provides tissue support.
  • Seriosis – is an osteoconductive bone void filler. It provides the appropriate environment for bone cells to thrive and function.  It’s multipurpose and used in trauma, infection, cancer, etc.  It dissolves after 6 months leaving space for the growth of natural tissues.
The presence of these products provides insight into the possibilities of silk use in medicine. Its potential to be employed in a multitude of applications such as tissue engineering, drug delivery, biomedical imaging, and cancer therapeutics remains at large.

While some of the products are achieving clinical translation, there are many avenues yet to be conquered eg silk in biomedical imaging, sensing, electronics, etc.
Silk is no doubt a promising biomaterial opening new vistas towards affordable healthcare solutions.






References 
https://serigenmed.com/
https://onlinelibrary.wiley.com/doi/full/10.1002/adhm.201800465

Comments

Popular posts from this blog

Penicillin to Peril

As our arsenal of antibiotics faces the relentless evolution of resistant microbes, the urgency to fortify our defenses intensifies.  In this narrative, we unravel the intricate tapestry of AMR and technological ingenuity flourishing to safeguard the foundations of modern medicine.  What is Antimicrobial resistance (AMR)? AMR is a natural process that occurs when microbes (bacteria, viruses, etc) evolve mechanisms that protect them from the effects of antimicrobials (antibiotics, antivirals, etc). Widespread antibiotic resistance is a significant component of AMR. Rise of AMR In 1928, the lucky accident of Penicillin discovery in Alexander Fleming's London laboratory changed the course of medicine. Ten years after its discovery - in 1939, extensive research began on Penicillin. It led to the establishment of “The Penicillin Project” - a collaboration that brought 15 pharmaceutical companies in the USA and the UK together to produce Penicillin. The first trials of Penicillin were c

Incoherent Diagnostics Innovation

India today imports a large numbe r of diag nostic medical devices. Despite the growth of the indigenous diagnostic industry, the imports in this sector have risen by nearly 41% in the last 2 years. What is the reason for this rise? Two parts of the growing rapid diagnostic industry are - the rapid card assays and their corresponding assay reading devices.  Rapid card assays are based on antigen–antibody reaction principles. This reaction produces colour, which indicates qualitative test results – positive or negative. For a long time diagnostics labs have used them (for a long time) as a preliminary test to see the presence of an analyte before the traditional testing method (Since traditional testing is expensive and time-consuming). Doing a card test helped diagnostic labs provide a quick (positive/ negative) response to doctors, who could start patient treatment earlier. The innovation of assay readers has helped quantify the qualitative results obtained from rapid card tests. So t

JanSehat - Improving Healthcare access for rural India

Around two months ago I got to be a part of a very exciting project aiming to build a first-of-its-kind healthcare network in rural India. Rural areas often face significant disparities in healthcare access and resources. The unique challenges faced in rural healthcare settings require innovative approaches and solutions.  The need to find creative solutions makes rural healthcare an exciting space to work in. Subsequently - once the patient gets his prescription - finding apt facilities for diagnostic tests or treatment is an onerous task. The nearest hospital does not provide all basic diagnostic tests. Patients have to use expensive private diagnostics services which take as long as 3 days to provide lab reports. The idea behind launching – “Project JanSehat” was to build a holistic healthcare model for rural India.  The program is a collaboration between - Spotsense x StepOne x PlusTrust. It is being piloted in the villages of Rajasthan and Madhya Pradesh. The pilot aims to be a